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Abstract 
Introduction: Congestive heart failure (CHF) is a serious condition and lack of medication adherence is one of the 
most common problems in the treatment of patients with CHF. This study aimed to determine the relationship between 
medication adherence and affective temperaments in patients with CHF.
Material and methods: This cross-sectional study was performed on 150 patients, who were referred to the cardio-
logy clinic of Ali Ibn Abi Talib Hospital of Zahedan, Iran in 2017–2018. Morisky Medication Adherence Scale (MMAS-8), 
Temperament Evaluation of Memphis, Pisa, Paris, and San Diego auto questionnaire (TEMPS-A), and Beck Depression 
Inventory-II (BDI-II) were used to collect data. For statistical analysis, SPSS-18 was used. Logistic regression was done for 
modeling the relationship between medication adherence.
Results: Generally, 54% of the patients were euthymic, while 16%, 23.33%, and 6.66% of them suffered from mild, 
moderate, and severe depression, respectively. The medication adherence was high, moderate, and low in 30.66%, 
46%, and 23.33% of the patients, respectively. There was a significant relationship between medication adherence and 
depressive (P = 0.049), cyclothymic (P = 0.01), and irritable (P = 0.01) affective temperaments. Only BDI-II score (P = 
0.018) was identified as predictors of drug adherence. 
Conclusions: Despite the statistically significant relationship between depressive, cyclothymic, and irritable tempera-
ments and adherence, affective temperaments cannot be considered as a predictor of adherence in patients with CHF.
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Introduction
Cardiovascular diseases are one of the most common 
chronic diseases worldwide, which are known as one 
of the main causes of morbidity and mortality [1, 2]. 
Congestive heart failure (CHF) is a chronic progressive 
condition, which is associated with the inefficiency of the 
heart in pumping and maintaining the blood flow [1]. 
According to the American Heart Association (AHA), 
about 5.8 million people in the USA and 22 million 
people worldwide suffer from heart failure. In addition, 
550,000 people are annually diagnosed with CHF [3, 4]. 
As the rate of CHF increases, it imposes heavy costs on 
the health systems [4]. 
The treatment process of patients with heart failure is 
difficult because of the complex and diverse medication 
regimens used for these patients [5]. Previous studies 
showed that about half of CHF patients do not comply 
with the regimens prescribed by their physicians, which 
can lead to devastating consequences and their re-
hospitalization [6]. 
Some factors such as hyperlipidemia, hypertension, 
high body mass index (BMI), diabetes mellitus, thyroid 
disorders, and health-related behaviors such as smoking 
and alcohol use play a major role in the incidence of car-
diovascular diseases; these conditions may also affect the 
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treatment process in CHF patients [7]. In some patients 
with asymptomatic cardiac dysfunction, medication 
non-adherence can lead to disease development and 
exacerbation [8]. After identification of the risk factors 
for heart failure, great attention has been focused on 
medication adherence and self-care behaviors in recent 
years [9, 10]. 
On the other hand, personality characteristics are a main 
important factor affecting the self-care behaviors of 
individuals [11]. Behavioral researchers have focused on 
the role of psychological factors and problems such as 
stress, tension, anxiety, depression, and type A behavior 
pattern on CHF [12]. Furthermore, they assessed other 
personality characteristics contributing to the incidence 
of CHF in addition to the classical elements [13]. Recent 
studies have highlighted the role of affective factors 
such as anger, hostility, depression, and anxiety in the 
development and progression of CHF [14]. As a result, 
personality characteristics are closely related to physical 
health [15]. 
Personality bridging inborn temperamental and learned 
characterological features associated with psychological 
and behavioral traits. Temperament is closer to “humoral 
theory” and represents the biological core of personality 
with the genetic and constitutional endowment. Char-
acter is more linked to nurturing, comprising acquired 
competencies during development, namely interpersonal 
development [16]. Some of the previous studies have 
revealed that medication adherence is been influenced 
by personality characteristics such as affective tempera-
ments [17].
Considering the high importance of CHF and the limited 
number of studies examining the relationship between 
affective temperaments and medication adherence, 
this study aimed to determine the relationship between 
affective temperaments and medication adherence in 
patients with CHF.
Material and methods 
This cross-sectional study was performed on patients re-
ferred to the cardiology clinic of Ali Ibn Abi Talib Hospital 
of Zahedan, Iran in 2017 and 2018 with the diagnosis 
of CHF. By using the available sampling method, 156 
patients were included in the study. First, the patients 
who met the inclusion criteria were selected. Of 156 
participants, 6 patients with incomplete questionnaires 
were excluded from the study. At the end, 150 subjects 
were enrolled in the study.
Inclusion and exclusion criteria 
The inclusion criteria were as follows: 1) age ≥ 18 years; 
2) diagnosis of CHD based on patient’s clinical record; 
3) at least three months elapsed from the diagnosis of 
CHF; 4) presence of New York Heart Association (NYHA) 
class II or III symptoms based on patient’s clinical record; 
5) left ventricular ejection fraction (LVEF) ≤ 45%; 6) the 
number of medications taken daily for the treatment of 
CHF ≤ 5; 7) proficiency in reading and writing Persian; 
and 8) providing informed consents.
Patients with severe cognitive problems, LVEF greater 
than 45%, and NYHA class I or IV symptoms were 
excluded from the study. Lack of patient’s consent to 
participate in the study was another exclusion criterion. 
Data collection tools
Morisky Medication Adherence Scale (MMAS-8)
Morisky Medication Adherence Scale (MMAS-8) is 
a structured, self-reported medication adherence 
measure [18]. This scale had been used to evaluate 
medication adherence in patients with heart failure [19]. 
The MMAS-8 has 8 items. Response choices for items 
1 to 7 are “Yes” or “No”. The 8th Item is a Likert-type 
question. The total score ranges from 0 to 8. Scores of 
less than 6 indicate low adherence, scores of 6 to < 8 
indicate moderate adherence and score = 8 indicates 
high adherence. To perform logistic regression, patients 
with scores less than 6 were considered as patients with 
non-adherence, and patients with scores of 6 and higher 
were considered as patients with adherence. The Persian 
version of MMAS-8, that has been used in the present 
study, validated by Moharamzad et.al. in 2015 [20].
TEMPS-A
To assess the patients’ affective temperaments, we used 
the Temperament Evaluation of Memphis, Pisa, Paris, and 
San Diego Auto questionnaire (TEMPS-A).
This questionnaire was designed by Akiskal et al. [21] 
to assess five affective temperaments including depres-
sive, cyclothymic, hyperthymic, irritable, and anxious 
temperaments. 
In the present study, we usedv a brief Persian version of 
TEMPS-A which is validated in Persian language [22]. This 
version of TEMPS-A consists of 35 yes/no items and the 
score ranges from 0 to 1 for each temperament.
Beck Depression Inventory-II (BDI-II)
Beck Depression Inventory was designed by Aaron T. 
Beck. This instrument is a 21-item, multiple-choice, self-
report inventory, which is used for measuring the severity 
of depression among patients. It consists of items related 
to depression symptoms (hopelessness and irritability), 
cognition (guilt or feelings of being punished), and physi-
cal symptoms (fatigue, weight loss, and lack of interest in 
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sex). BDI-II is a revision of BDI, designed in 1996. BDI-II 
is validated in Persian language [23].
Ethical considerations
The present study was approved by the Ethics Commit-
tee of Zahedan University of Medical Sciences. All the 
participants were assured in terms of data confidentiality 
and informed consent were obtained from all subjects. 
Data analysis
All participants in this study completed the questionnaire 
related to medication adherence, affective tempera-
ments, and depression. Afterward, the obtained data 
were recorded on the prepared sheets. The collected 
data were entered into SPSS version 18. The distribution 
of samples and comparison of quantitative variables 
were evaluated by the Kolmogorov-Smirnov test, t-test, 
and Man-Whitney test. The comparison of qualitative 
variables was performed by the Chi-square test. Also, 
logistic regression was used for modeling the relation-
ship between medication adherence and the associated 
variables.
Results
In general, 54.66% of the patients were female, and 
the mean age of the patients was 48.48 ± 12.25 years. 
In terms of marital status, 7.33%, 74.66%, 8%, and 
10% of the patients were single, married, divorced, and 
widowed, respectively. Moreover, 20%, 23.33%, 18%, 
and 1.33% of the patients had a high school, associate 
degree, bachelor’s degree, and master’s degree, respec-
tively; The remainder of the subjects had basic education.
The level of medication adherence was high, moderate, 
and low in 30.66%, 46%, and 23.33% of the patients, 
respectively.
BDI-II showed that 54% of the patients were euthymic, 
whereas 16%, 23.33%, and 6.66% of them suffered 
from mild, moderate, and severe depression, respectively.
The mean depressive temperament score was 0.562 ± 
0.16. Moreover, the mean temperament scores were 
0.447 ± 0.298, 0.508 ± 0.19, 0.305 ± 0.194, and 
0.56 ± 0.228 in cyclothymic, hyperthymic, irritable, and 
anxious temperaments, respectively. 
The comparison of medication adherence in CHF patients 
based on gender, marriage statues educational level, and 
severity of depression are shown in Table 1.
For evaluating the relationships between affective tem-
peraments, BDI-II score, and medication adherence were 
examined by t-test and Mann-Whitney test. According to 
the obtained results, BDI-II score, depressive, cyclothymic, 
and irritable temperaments were inversely related to 
medication adherence. However, there was no significant 
Table 1. The comparison of demographic characteristics and depression of patients with high, moderate, and low 
medication adherence
Total Medication adherence P-value
High Moderate Low
30.66% 46% 23.33%
Gender Male 45.33% 28.4% 44.8% 26.9% 0.519
Female 54.66% 33.7% 47% 19.3%
Marriage 
statues
Single 7.33% 22.2% 22.2% 55.6% 0.029
Married 74.66% 32.7% 49.6% 17.7%
Divorced 8% 23.1% 23.1% 53.8%
Widow 10% 33.3% 53.3% 13.3%
Education Basic 37.33% 31% 55.2% 13.8% 0.001
High school 20% 30% 46.7% 23.3%
Associate diploma 23.33% 47.1% 44.1% 8.8%
Bachelor 18% 14.8% 29.6% 55.6%
Master’s degree 1.33% 0 0 100%
Depres-
sion
Normal 54% 49% 40.8% 10.2% 0.001
Mild 16% 10% 50% 40%
Moderate 23.33 27.3% 33.3% 39.4%
Severe 6.66% 25% 58.3% 16.7%
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relationship between medication adherence and anxious 
and hyperthymic temperaments (Table 2).
For modeling the relationships between medication 
adherence and the related variables, logistic regression 
analysis was used. To determine the association between 
drug adherence and gender, age, depression, and tem-
peraments, multiple correlation coefficient (R = 0.358), 
coefficient of determination (R2 = 0.128), pure deter-
mination coefficient (R-2 = 0.104), and standard error 
of estimate (SEE = 1.529) were calculated. According 
to the obtained results, about 12% of the medication 
adherence variance score was explained by effective 
predictor variables; therefore, the regression was linear 
(F = 5.342; P > 0.005). 
Simultaneous regression analysis showed that only BDI-II 
scores (P = 0.018) were identified as predictors of drug 
adherence. Age, gender, and temperament variables 
could not predict medication adherence (Table 3).
Discussion
According to the results of the present study, high medi-
cation adherence was observed in less than one-third of 
the cases. About half of the patients showed moderate 
medication adherence, and low medication adherence 
was observed in more than one-fifth of cases. 
This study reflected a significant linear relationship be-
tween depression, depressive temperament, cyclothymic 
temperament, and irritable temperament with drug 
adherence. Our results demonstrated a lack of predictive 
power of different temperaments on medication adher-
ence in CHF patients.
Non-adherence is a common problem among CHF pa-
tients [24–26]. Previous studies have been conducted 
about the causes of non-adherence with treatments. 
Some of these studies have examined the relationship 
between psychological factors and medication adher-
ence. For the first time, lack of response to treatment 
due to non-adherence with drug and dietary regimens 
was introduced as the main risk factor in patients with 
heart failure by Ghali et al. [27]. Based on the study by 
Lennie et al., non-adherence with dietary regimen was 
observed in three-quarters of CHF patients [26]. This 
finding is like the results of the present study in which 
only 31.3% of patients had high medication adherence. 
Additionally, our results are in accordance with those of 
Parsa-Yekta et al. [28] study, in which the rate of drug 
adherence was estimated at 28% in CHF patients and 
poor drug adherence was observed in the majority of 
patients with CHF. 
However, the rate of medication adherence was higher in 
the study by Jahanpour et al. [29]. This discrepancy might 
be due to different study designs, different demographic 
characteristics, and different methods for evaluating drug 
adherence. On the other hand, the bias in the selection of 
patients in our study might have affected drug adherence 
rate, as our study was performed on the patients pre-
sented to the cardiology clinic and moderate symptoms 
(NYHA class II or III); therefore, it cannot be an accurate 
reflection of the CHF patients’ population.
Ghali et al. found that low adherence to treatment was 
higher in males than the females [27], which is incon-
sistent with our result. However, like our study, Hadian 
and Mokhbery did not show any significant difference 
in medication adherence between the two genders [30], 
which was confirmed by the other similar studies [29, 31].
According to our findings, there was no statistically 
significant relationship between age and drug adher-
ence. Some studies have shown that elderly patients 
may lack self-care and medication adherence behaviors 
due to disabilities of aging and problems such as cog-
nitive problems [32]. Medication adherence was better 
in married patients than the single subjects, which was 
confirmed by other studies [5, 28]. One reason may be 
a higher prevalence of psychiatric disorders in single or 
divorced patients compared to married ones and these 
disorders can decrease medication adherence.




Depressive Temperament 0.521 ± 0.185 0.597 ± 0.137 0.552 ± 0.155 0.049
Cyclothymic Temperament 0.339 ± 0.22 0.503 ± 0.183 0.483 ± 0.188 0.01
Hyperthymic Temperament 0.574 ± 0.194 0.459 ± 0.189 0.521 ± 0.163 0.11
Irritable Temperament 0.225 ± 0.185 0.313 ± 0.195 0.384 ± 0.169 0.01
Anxious Temperament 0.453 ± 0.266 0.599 ± 0.215 0.533 ± 0.198 0.218
BDI-II Score 11.3 ± 8.2 15.1 ± 7.9 18.5 ± 9.9 0.001
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Our study demonstrated that medication adherence 
is low in depressed patients, which can be justified 
considering low motivation of patients for treatment. 
According to the obtained results, logistic regression did 
not reflect any predictive association between affective 
temperaments and medication adherence. Hall et al. [33] 
showed that the anxious temperament can facilitate the 
diagnosis of diabetes in the early stages of the disease; 
however, similar to our findings, there was no significant 
relationship between the anxious temperament and self-
care in diabetic patients at 6-month follow-up. 
These findings were inconsistent with the obtained re-
sults of Shamsi et al. [17]. They showed that the irritable 
temperament was a predictor of drug adherence. This 
may be as a result of the differences in sample charac-
teristics or sample size. Also, the patients in our study 
suffered from CHF, while the study of Shamsi et al. was 
performed on the patients with diabetes.
Conclusion
Very few studies have been conducted about the relation-
ship affective temperaments and medication adherence in 
patients with CHF. This may reflect the lack of attention to 
the relationship between medication adherence and per-
sonality characteristics and further studies in this area in the 
future can help clarify different aspects of this relationship 
and are therefore suggested. According to the findings 
of the present study, affective temperaments cannot be 
considered as a predictor of adherence in patients with CHF.
Limitations and strengths
In this study, the relationship between medication adher-
ence and affective temperaments was assessed. In fact, 
no similar studies have been conducted in the Iranian 
population.
We used available sampling methods for subject selec-
tion, thus, future studies in other centers and with larger 
sample sizes are recommended. 








Fixed amount 1.534 0.837 1.834 0.069
Gender 0.376 0.257 0.116 1.462 0.146
Age –0.03 0.01 –0.225 –2.894 0.059
Depression 0.031 0.013 0.232 0.387 0.018
Affective temperament (total) 0.007 0.011 0.062 0.629 0.531
*Standard error of measurement
Given this study was carried out on patients referred to 
cardiology clinic, it cannot be an accurate reflection of 
the CHF patients’ population, therefore, future studies 
are recommended in this regard.
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